Production (Stage)
Sanara MedTech Inc.
SMTI
$29.00
-$0.31-1.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.42% | 48.70% | 35.24% | 27.97% | 19.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.42% | 48.70% | 35.24% | 27.97% | 19.42% |
| Cost of Revenue | -2.91% | 25.78% | 13.74% | -8.17% | -11.09% |
| Gross Profit | 29.75% | 51.28% | 37.87% | 33.80% | 24.26% |
| SG&A Expenses | 32.41% | 34.02% | 33.76% | 27.83% | 24.85% |
| Depreciation & Amortization | 1.72% | 0.62% | 10.64% | 37.55% | 41.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.72% | 39.18% | 30.69% | 21.00% | 17.12% |
| Operating Income | -30.21% | 38.03% | 15.20% | 28.32% | 4.29% |
| Income Before Tax | -96.08% | -548.09% | -163.32% | -89.11% | -47.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -96.08% | -548.09% | -163.32% | -89.11% | -47.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -99.43% | 540.32% | -26.88% | -34.38% | -9.11% |
| Net Income | -99.93% | -548.65% | -169.50% | -91.72% | -49.78% |
| EBIT | -30.21% | 38.03% | 15.20% | 28.32% | 4.29% |
| EBITDA | -94.23% | 76.99% | 58.83% | 65.52% | 44.73% |
| EPS Basic | -96.47% | -537.10% | -163.55% | -86.23% | -45.39% |
| Normalized Basic EPS | -92.03% | 2.15% | -28.74% | 1.28% | -9.28% |
| EPS Diluted | -96.47% | -537.10% | -163.55% | -86.23% | -45.39% |
| Normalized Diluted EPS | -92.03% | 2.15% | -28.74% | 1.28% | -9.28% |
| Average Basic Shares Outstanding | 1.79% | 1.78% | 2.22% | 2.95% | 3.01% |
| Average Diluted Shares Outstanding | 1.79% | 1.78% | 2.22% | 2.95% | 3.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |